Central Serous Retinopathy
serous retinopathy is an eye condition where fluid accumulates underneath the
retina causing distortion and visual loss. Patients are typically 20-50 years
old and often complain of a sudden, painless loss of vision.
occurs 8-10 times more commonly in men than in women. It is felt that this may be a stress-related condition as it is
more common in patients with “Type A” personalities.
may be asymptomatic unless the central part of the retina (macula) is affected.
In these cases, they note decreased or blurred vision, distortion
(metamorphopsia), micropsia (small image size), and abnormal color vision
angiography is a diagnostic test in which intravenous fluorescein dye is
administered and photographs are taken of the eyes. In central serous
retinopathy, the angiogram typically shows, dye accumulating beneath the retinal detachment but does not go beyond
its borders. Most cases show one leakage point.
Optical Coherence Tomography (OCT)
OCT is an
excellent diagnostic test which clearly demonstrated the serous detachment,
especially when the serous detachment is shallow.
patients, observation is all that is necessary. If possible, steps to reduce
external stressors should be taken. In addition, we advise patients to avoid
corticosteroids if possible, as they can worsen the disease.
Laser at site of leakage can accelerate
resolution but does not result in a better visual acuity, and does not reduce the
rate of recurrence. Treatment can be with either laser
photocoagulation or Photodynamic Therapy (PDT).
However there is evidence that treatment with specific antihypertensive therapy may also cause resolution. These options will be discussed to see which best suits you. We generally treat patients who meet with the following characteristics:
• A non-resolving serous detachment for at
least four months
• A site of leakage away from the foveal center
• An occupational need for expedited visual
spontaneous visual recovery is the very common. Approximately 40-50% will
recover in less than 6 weeks. This number increases to 80-90% within 6 months. but some patients may
still have minor persistent visual complaints.
This is a condition that may recur. As many as
40-50% of patients will have one or more recurrences, which can occur many
About 10% of patients will have 3 or more episodes.